167 related articles for article (PubMed ID: 6098230)
21. Dopamine receptor changes in response to prolonged treatment with L-dopa.
Groppetti A; Flauto C; Parati E; Vescovi A; Rusconi L; Parenti M
J Neural Transm Suppl; 1986; 22():33-45. PubMed ID: 2946813
[TBL] [Abstract][Full Text] [Related]
22. Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors.
Gnegy M; Uzunov P; Costa E
J Pharmacol Exp Ther; 1977 Sep; 202(3):558-64. PubMed ID: 19618
[No Abstract] [Full Text] [Related]
23. Studies of neurotensin-dopamine receptor interactions in striatal membranes of the male rat. The influence of 6-hydroxydopamine-induced dopamine receptor supersensitivity.
Fuxe K; Agnati LF; Martire M; Neumeyer A; Benfenati F; Frey P
Acta Physiol Scand; 1986 Jan; 126(1):147-9. PubMed ID: 3006432
[No Abstract] [Full Text] [Related]
24. Rapidly induced dopaminergic supersensitivity: D1/D2 receptor participation and its prevention by an MAO-inhibitor.
Kleinman A; Tieppo CA; Florez GM; Felicio LF; Nasello AG
Pharmacol Biochem Behav; 2006 Nov; 85(3):592-600. PubMed ID: 17157367
[TBL] [Abstract][Full Text] [Related]
25. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
Okuyama S; Shimamura H; Hashimoto S; Aihara H
Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
[TBL] [Abstract][Full Text] [Related]
26. Ganglioside interactions with the dopaminergic system of rats.
Tilson HA; Harry GJ; Nanry K; Hudson PM; Hong JS
J Neurosci Res; 1988; 19(1):88-93. PubMed ID: 3125345
[TBL] [Abstract][Full Text] [Related]
27. Postsynaptic striatal dopamine agonist or antagonist actions of (+) or (-) 3-PPP and modification after receptor deafferentation.
Oberlander C; Boissier JR
J Pharmacol; 1983; 14(4):401-4. PubMed ID: 6423905
[TBL] [Abstract][Full Text] [Related]
28. Light modulates dopamine-regulated Walsh inhibitor activity and dopamine-dependent cyclic AMP accumulation in the rabbit retina.
Nowak JZ; Zawilska J; Sek B; Schorderet M
Pol J Pharmacol Pharm; 1990; 42(5):457-70. PubMed ID: 1983030
[TBL] [Abstract][Full Text] [Related]
29. Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment.
Groppetti A; Ceresoli G; Mandelli V; Parenti M
J Pharmacol Exp Ther; 1990 Jun; 253(3):950-6. PubMed ID: 2162953
[TBL] [Abstract][Full Text] [Related]
30. Effects of intrastriatal infusion of D2 receptor antisense oligonucleotide on apomorphine-induced behaviors in the rat.
Rajakumar N; Laurier L; Niznik HB; Stoessl AJ
Synapse; 1997 Jul; 26(3):199-208. PubMed ID: 9183809
[TBL] [Abstract][Full Text] [Related]
31. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
[TBL] [Abstract][Full Text] [Related]
32. Presynaptic dopamine receptors in the pithed rat: characterization with apomorphine and comparison with central dopamine autoreceptors.
Hietala J; MacDonald E; Scheinin M
Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):291-7. PubMed ID: 3799208
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of postsynaptic DA2 receptors produces jerks in reserpine-treated rats.
Grabowska-Andén M; Andén NE
J Pharm Pharmacol; 1983 Aug; 35(8):543-5. PubMed ID: 6137550
[No Abstract] [Full Text] [Related]
34. Effect of chronic apomorphine on the development of denervation supersensitivity.
Robin M; Forler C; Palfreyman MG
Pharmacol Biochem Behav; 1985 Apr; 22(4):547-51. PubMed ID: 3921992
[TBL] [Abstract][Full Text] [Related]
35. Apomorphine-induced inhibition of neostriatal activity is enhanced by lesions induced by 6-hydroxydopamine but not by long-term administration of amphetamine.
Alloway KD; Rebec GV
Neuropharmacology; 1984 Sep; 23(9):1033-9. PubMed ID: 6096755
[TBL] [Abstract][Full Text] [Related]
36. Presynaptic inhibition of dopamine synthesis in rat striatum: effects of chronic dopamine depletion and receptor blockade.
Reches A; Wagner HR; Jackson-Lewis V; Fahn S
Brain Res; 1985 Nov; 347(2):346-9. PubMed ID: 3933764
[TBL] [Abstract][Full Text] [Related]
37. Implications of dopamine agonist-induced hypothermia following increased density of dopamine receptors in the mouse.
Feigenbaum JJ; Yanai J
Neuropharmacology; 1985 Aug; 24(8):735-41. PubMed ID: 3939327
[TBL] [Abstract][Full Text] [Related]
38. The effect of dopamine receptor agonist treatment on haloperidol-induced supersensitivity in mice.
Fayle P; Jackson DM; Jenkins OF; Lafferty PA
Pharmacol Biochem Behav; 1985 Nov; 23(5):715-20. PubMed ID: 4080755
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of apomorphine on spinal reflex activity following 6-hydroxydopamine or long-term haloperidol pretreatment.
Jensen TS; Christensen NJ; Smith DF
J Neural Transm; 1986; 65(2):125-34. PubMed ID: 3084706
[TBL] [Abstract][Full Text] [Related]
40. Changes in the sensitivities of dopamine receptors to chronic treatment with imipramine & haloperidol in rats.
Pradhan N; Arunasmitha AS
Indian J Med Res; 1990 Aug; 92():293-7. PubMed ID: 2228076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
